Abstract: A shape memory alloy (SMA) actuator assembly (1) comprising: a movable part (100); a support structure (3); one or more SMA wires arranged, on contraction, to tilt the movable part relative to the support structure about two orthogonal axes that are perpendicular to a primary axis (O) of the support structure; and axial translation constrainers (16) configured to limit axial translation of the movable part relative to the support structure along the primary axis of the support structure, wherein the axial translation constrainers are arranged to prevent all points of the movable part from simultaneously reaching their most extreme position along the primary axis of the support structure allowed by the range of possible tilt of the movable part relative to the support structure.

Abstract: A shield includes a cover, a first frame, and a second frame. The first frame is configured to be attached to a first side of a circuit board. The second frame is configured to be attached to a second side of the circuit board. The cover is configured to be attached to the first frame and the second frame such that the cover is configured to overlap a portion of the first side of the circuit board, a portion of the second side of the circuit board, and a portion of a third side of the circuit board. The cover, the first frame, and the second frame are configured to together define a housing. An apparatus includes the shield and the circuit board.

Abstract: The present invention is based upon the finding that certain conditions, diseases and/or disorders affecting the skin, are associated with reduced expression of an enzyme exhibiting oxidoreductase activity. Accordingly, the invention provides oxidoreductase enzymes and/or genes encoding the same for use in treating or preventing disorders of the skin and method for generating Type VII collagen suitable for use in treating disorders of the skin.

Abstract: The present invention discloses a series of genes and/or proteins associated with cutaneous squamous cell carcinoma (cSCC) and provides polynucleotides and/or polypeptides for use in the treatment and/or prevention of cSCC. The invention further relates to methods of diagnosing cSCC and provides oligonucleotides/polypeptide probes and primers.